Cytotoxic Potencies of Zinc Oxide Nanoforms in A549 and J774 Cells
Open Access
- 3 October 2024
- journal article
- research article
- Published by MDPI AG in Nanomaterials
- Vol. 14 (19) , 1601
Abstract
Zinc oxide nanoparticles (NPs) are used in a wide range of consumer products and in biomedical applications, resulting in an increased production of these materials with potential for exposure, thus causing human health concerns. Although there are many reports on the size-related toxicity of ZnO NPs, the toxicity of different nanoforms of this chemical, toxicity mechanisms, and potency determinants need clarification to support health risk characterization. A set of well-characterized ZnO nanoforms (e.g., uncoated ca. 30, 45, and 53 nm; coated with silicon oil, stearic acid, and (3-aminopropyl) triethoxysilane) were screened for in vitro cytotoxicity in two cell types, human lung epithelial cells (A549), and mouse monocyte/macrophage (J774) cells. ZnO (bulk) and ZnCl2 served as reference particles. Cytotoxicity was examined 24 h post-exposure by measuring CTB (viability), ATP (energy metabolism), and %LDH released (membrane integrity). Cellular oxidative stress (GSH-GSSG) and secreted proteins (targeted multiplex assay) were analyzed. Zinc oxide nanoform type-, dose-, and cell type-specific cytotoxic responses were seen, along with cellular oxidative stress. Cell-secreted protein profiles suggested ZnO NP exposure-related perturbations in signaling pathways relevant to inflammation/cell injury and corresponding biological processes, namely reactive oxygen species generation and apoptosis/necrosis, for some nanoforms, consistent with cellular oxidative stress and ATP status. The size, surface area, agglomeration state and metal contents of these ZnO nanoforms appeared to be physicochemical determinants of particle potencies. These findings warrant further research on high-content “OMICs” to validate and resolve toxicity pathways related to exposure to nanoforms to advance health risk-assessment efforts and to inform on safer materials.Keywords
Funding Information
- Chemicals Management Plan (CMP)
This publication has 70 references indexed in Scilit:
- Surface modifications affect iron oxide nanoparticles' biodistribution after multiple‐dose administration in ratsJournal of Biochemical and Molecular Toxicology, 2020
- Physiological roles of zinc transporters: molecular and genetic importance in zinc homeostasisThe Journal of Physiological Sciences, 2017
- Influence of pH, particle size and crystal form on dissolution behaviour of engineered nanomaterialsEnvironmental Science and Pollution Research, 2016
- Toxicity of antimony, copper, cobalt, manganese, titanium and zinc oxide nanoparticles for the alveolar and intestinal epithelial barrier cells in vitroCytotechnology, 2016
- The effect of Fe2O3 and ZnO nanoparticles on cytotoxicity and glucose metabolism in lung epithelial cellsJournal of Applied Toxicology, 2015
- Critical experimental parameters related to the cytotoxicity of zinc oxide nanoparticlesJournal of Nanoparticle Research, 2014
- Changes in protein expression in rat bronchoalveolar lavage fluid after exposure to zinc oxide nanoparticles: an iTRAQ proteomic approachRapid Communications in Mass Spectrometry, 2014
- Zinc Oxide Nanoparticles: Synthesis, Antimicrobial Activity and Food Packaging ApplicationsFood and Bioprocess Technology, 2012
- Zinc Is the Toxic Factor in the Lung Response to an Atmospheric Particulate SampleToxicology and Applied Pharmacology, 2000
- Regulation of Promoter-CAT Stress Genes in HepG2 Cells by Suspensions of Particles from Ambient AirFundamental and Applied Toxicology, 1997